Edesa Biotech Inc — Quarterly Financial Statistics (NASDAQ:EDSA) | MetaTrader

Open full chart

Financials

Overview Finanzbericht Statistics Dividends

Quarterly Annual

Cash from operating activities -856.48 K8.82 M1.5 M5.42 M1.7 M1.7 M2.1 M 10.92 M Cash from investing activities ——————— — Cash from financing activities 106.02 K-31.43 K2.07 M14.77 M0186.48 K3.36 M 18.31 M Free cash flow -856.48 K8.82 M1.5 M5.42 M1.7 M1.7 M2.1 M 10.92 M

Nachrichten

U.S. stocks higher at close of trade; Dow Jones Industrial Average up 0.76%

Edesa-Biotech-Aktie schießt nach positiven Phase-3-Studiendaten in die Höhe

Edesa Biotech stock surges on positive Phase 3 trial data

Edesa Biotech reports mortality reduction in phase 3 trial

Edesa Biotech erweitert "At-the-Market"-Angebot auf 2,26 Millionen US-Dollar/n

Edesa Biotech increases at-the-market offering limit to $2.26 million

Edesa Biotech, Inc. (EDSA) Presents at LSX Investival Showcase Europe 2025 - Slideshow (NASDAQ:EDSA) 2025-11-17

Edesa Biotech meldet signifikanten Erfolg in Phase-3-Studie zu ARDS-Medikament

Edesa’s ARDS drug shows 25% reduction in death risk in phase 3 trial

Edesa Biotech reports positive Phase 3 results for ARDS drug candidate

Edesa Biotech Reports Fiscal 2nd Quarter 2025 Results

Dow Jumps Over 100 Points; Deere Posts Upbeat Earnings - AppLovin (NASDAQ:APP), Dutch Bros (NYSE:BROS)